Biotech | May 26, 2026
Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
AAV vectors are widely used in gene therapy for their strong therapeutic potential
AAV vectors are widely used in gene therapy for their strong therapeutic potential
A one-shot gene-editing cholesterol therapy could soon be a reality
The recommendation is powered by blockbuster results from the pivotal Phase III SERENA-6 trial
The company is also highlighting early-stage innovation in antibody-drug conjugates and in vivo CAR-T therapy
With standout ADC and t-cell engager response data across hard-to-treat cancers
The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors
The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Transition to a fermentation-based globally integrated CDMO platform
Approved product is therapeutically equivalent to Synthroid of AbbVie and is indicated for the treatment of congenital or acquired hypothyroidism
Subscribe To Our Newsletter & Stay Updated
